BioPharma Credit PLC (OTCMKTS:BOPCF – Get Free Report) was the recipient of a large decline in short interest in the month of May. As of May 15th, there was short interest totaling 633 shares, a decline of 81.8% from the April 30th total of 3,486 shares. Based on an average trading volume of 48,182 shares, the short-interest ratio is currently 0.0 days.
BioPharma Credit Price Performance
BOPCF remained flat at $0.96 during trading hours on Friday. The company has a 50 day simple moving average of $0.94 and a 200-day simple moving average of $0.90. BioPharma Credit has a fifty-two week low of $0.83 and a fifty-two week high of $1.02.
BioPharma Credit Company Profile
BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios.
Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms.
Featured Stories
- Five stocks we like better than BioPharma Credit
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
- Palomar’s High-Risk Insurance Strategy Is Paying Off Big
- Marvell’s Pullback May Be the Setup Bulls Were Waiting For
- Flight Path to Profits: American Airlines Bets on SpaceX
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
